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Abstract: Tuberculous pleuritis is a good human model to understand the local and protective immune 
response against tuberculosis, due to the self-limitedness of the disease. Although the cellular immune 
response has been well characterised in tuberculous pleurisy, much less is known about the humoral 
immune response operating at the site of infection. To understand the humoral immune response, B 
cells were enumerated in peripheral blood mononuclear cells (PBMC) and pleural fluid mononuclear 
cells (PFMC) of tuberculous (TP) and non-tuberculous pleuritis patients (NTP). The levels of IgG, IgA 
and IgM antibodies for PPD, culture filtrate (CF) and sonicate antigens (Son Ag) were assessed in 
plasma (BL) and pleural fluid (PF) and a western blot was carried out with the CF antigen. The 
percentage of CD19+B-cells was similar in PBMC and PFMC of TP patients but was significantly 
lower in PFMCs of NTP patients. The IgG levels for PPD and CF antigens were higher in PF of TP 
than NTP patients. The antigen recognition patterns did not differ in plasma and pleural fluid of the 
same patient in both groups pointing out the passive diffusion of the plasma to the pleura. The antigens 
25, 31, 33, 70, 110, 124 and 132 kDa were recognized exclusively by the TP patients. Thus our study 
showed that the local humoral response in TP did not differ from the systemic response. However, the 
humoral response differed in TP patients when compared to NTP patients. 
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INTRODUCTION 
 
 Tuberculosis is the leading cause of death and 
continues to be the foremost cause of pleural effusion[1]. 
Of all the extra pulmonary manifestation of 
tuberculosis, tuberculous pleuritis (TP) is predominant 
and is a pauci-bacillary disease occurring due to the 
delayed type hypersensitive response to the 
mycobacterial antigens. Immunological reactivity 
against Mycobacterium tuberculosis is 
compartmentalized in TP and is often characterized by 
resolution of the disease without chemotherapy[2,3]. The 
compartmentalized immune response in TP allows it to 
be exploited as a human model to understand the local 
and protective host immune functions. 
 The different antigenic components of M. 
tuberculosis have the innate ability to trigger adaptive 
immune response in the host. It is well known that in 
tuberculosis, cell mediated immune response (CMI) is 
host-protective. The mycobacterial antigens that are 
good enough to elicit CMI are also equally effective in 
evoking antibody mediated humoral immune response. 
The current understanding of the humoral immune 
response to tuberculosis is from the serological studies 
that by and large aimed at developing a serodiagnostic 
test to identify tuberculosis. Though these studies 
provide information on the pattern of antibody response 
at the systemic level, much lesser is known about the 
antibody response at the site of infection.   
 The genomic studies on M. tuberculosis have 
predicted 3924 protein-coding sequences (CDS) from 
the genome[4]. The recent study by Mawuenyega et al 
has characterized 1044 protein and their corresponding 
localizations with respect to cell wall, membrane and 
cytoplasm by high-throughput proteomics and 
computational approaches[5].  To date, in the 
Tuberculist genome analysis worldwide web server, 
there are 113 proteins annotated as secreted and 49, as 
excreted proteins of M.tuberculosis[4]. The exported and 
secreted proteins of mycobacteria are hypothesized, by 
several researchers as the key protective antigens[6-10]. 
This is due to the observations that live but not dead 
bacilli induce a protective T-cell response and that the 
cell surface and secreted antigens are the first 
encountered and presented by the host immune 
response. In addition to the protective T-cell response, 
the secreted proteins are also recognized by humoral 
arm of the immune response. The most studied secreted 
proteins of M. tuberculosis are ESAT-6 (early secretory 
antigenic target), CFP10, 38kDa, 16kDa and antigen 85 
complex[11-16].  The ability of these proteins to elicit 
serological response make them to be utilized as the 
candidates for sero-diagnosis.  
 The knowledge of antibody response at the site of 
infection may possibly help us in identifying newer 
antigens that are immunogenic and crucial for 
provoking host antibody response or that may aid in 
sero-diagnosis. Hence, in the present study we aimed to 
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evaluate the humoral immune response in TB pleuritis 
i.e at the site of infection. Hence, we assessed the levels 
of different antibodies against different mycobacterial 
antigens in both plasma and pleural fluid of the same 
patient by ELISA. Also we compared the localized and 
systemic antibody response against the secreted 
antigens by western blot analysis.  
 
SUBJECTS AND METHODS 
 
Study Group: In this study, we enrolled a total of 74 
patients with pleural effusion from Government 
General Hospital. The study was approved by the 
institutional ethical committee of Government General 
Hospital, Chennai. The written and informed consent 
was obtained from each study participant. Patients with 
HIV infection were excluded from the study. The blood 
and the pleural fluid collected for the therapeutic 
purpose, before the start of the treatment was utilized 
for this study. All these subjects were Mantoux positive 
and showed an induration of more than 10 mm. Based 
on the diagnosis, the study subjects were classified into 
two groups. 
 
Tuberculous pleuritis subjects (TP): This group 
consists of 44 patients, who had pleural effusion due to 
tuberculous infection. These subjects were sputum 
smear positive for the acid-fast bacilli and were 
Mantoux positive. Further diagnosis of pleural 
tuberculosis was based on positive culture of M. 
tuberculosis on Lowenstein-Jenson medium from 
pleural fluid and by PCR to detect the bacilli using 
IS6110 primers in pleural fluid, supported by the 
radiographic and clinical data.  
 
Non-tuberculous pleuritis subjects (NTP): This 
group consists of 30 subjects who had exudative pleural 
effusion due to causes other than tuberculosis. The 
etiologies of these patients are Malignancy (N=24), 
Para pneumonic effusion (N=4) and exudative effusion 
due to secondary infections to autoimmune disorders 
(N=2). The effusion had lymphoctyic predominance. 
The diagnosis was based on the cytology of the pleural 
fluid, demonstration of the causative organism by 
appropriate culture methods and relevant clinical 
findings.  
 
Antigens: Purified Protein Derivative was obtained 
from Central Veterinary Lab, Weybridge, U.K. 
 Culture filtrate antigen was prepared from M. 
tuberculosis H37Rv grown in Sauton’s liquid medium 
for 5 weeks. For   the   preparation of culture filtrate, 
the proteins   in the culture supernatant were 
precipitated with   90%   ammonium sulphate 
saturation. The precipitate was dissolved and dialyzed 
against 0.1M PBS.   
 
 
 The sonicate antigen was prepared by sonicating 
the pellet containing bacilli obtained after removing the 
culture supernatant. The sonication was carried out in 6 
cycles of each 30 seconds on and 30 seconds off in PBS 
(pH 7.0) followed by centrifugation  at 8000rpm for 
10min. The supernatant was filtered through 0.45µm 
pore size membrane.  
 The quantification of protein was done using the 
protein estimation kit following manufacturer’s 
instruction (Bangalore Genei, India) 
 
Flow cytometry: The percentage of B-cells in the 
peripheral blood mononuclear cells (PBMC) and 
pleural fluid mononuclear cells (PFMC) were assessed 
by flow cytometry. The cells were incubated with CD3 
FITC/ CD19 PE antibodies for 30 min at 40C. The cells 
were fixed in 1% paraformaldehyde (W/V) and 
acquired using fluorescence-activated cell scan (FACS, 
Becton Dickinson). The analyses were done using 
CellQuest software. A total of 10, 000 events for each 
sample were acquired. The data were expressed as 
percentage of total lymphocytes. 
 
ELISA: ELISA was carried out to estimate the 
immunoglobulins IgG, IgA and IgM levels against 
PPD, culture filtrate (CF) and sonicate antigens (Son 
Ag). The antigens were coated on the polyvinyl 
microtitre ELISA plates (Costar, USA) at the 
concentration of 5µg/ml. After overnight incubation, 
non-specific adsorption of protein was blocked with 
1%BSA in PBS for one hour at 37°C. The plasma and 
pleural fluid samples were added in 1:100 dilutions in 
triplicates. Peroxidase-labeled Goat anti-human IgG, 
IgA and IgM were used at the dilutions of 1:10,000, 1: 
5000 and 1: 10,000 respectively. The enzymatic 
substrate used was H2O2 mixed with the chromogen 
substrate tetramethylbenzidine (Bangalore Genei, 
India).  The absorbance was read at 450nm using an 
ELISA plate reader (Molecular devices, SPECTRA 
MAX-250, USA). 
 
Western blotting: The culture filtrate antigen was 
denatured under reducing condition at 100oC in a sand 
bath for 5 minutes and separated by SDS-PAGE on 
12%gel. The fractionated proteins were 
electrophoretically transferred onto PVDF membrane 
(Bio Rad) in a transblot unit (Transblot, BioRad). 
Membranes were blocked with 1% BSA in PBS 
containing 0.1% tween-20. The membrane was cut into 
5-7mm wide strips and then incubated with plasma and 
pleural fluid samples in 1:100 dilution. Peroxidase 
labeled goat-anti-human IgG was used as a secondary 
antibody in 1:5000 dilution. The binding of the 
antibodies to the specific protein was revealed by using 
Diaminobenzidine (DAB) chromogen as substrate. 
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Table 1a:  Antibody levels in tuberculous pleuritis subjects (N=44) 
 PPD CF Son Ag 
 BL PF BL PF BL PF 
IgG 1.2±0.1 1±0.1 1.6±0.12 1.4±0.12* 0.7±0.09 0.7±0.1 
IgA 0.5±0.05 0.4±0.06 0.4±0.04 0.4±0.05 0.50±0.03 0.50±0.04 
IgM 0.3±0.05 0.26±0.04* 0.4±0.05 0.36±0.04 0.6±0.06 0.5±0.05 
 
Table 1b: Antibody levels in non-tuberculous pleuritis subjects (N=30) 
 PPD CF Son Ag 
 BL PF BL PF BL PF 
IgG 1.0±0.09 0.81±0.08*# 1.32±0.1 1±0.09*# 0.9±0.1 0.7±0.08* 
IgA 0.6±0.07 0.4±0.06* 0.5±0.06 0.3±0.05* 0.50±0.05 0.4±0.06* 
IgM 0.4±0.04 0.3±0.06* 0.4±0.05 0.3±0.05* 0.6±0.06 0.4±0.06* 
 The antibody isotype levels in plasma (BL) and pleural fluid (PF) of 44 tuberculous (A) and 30 non-tuberculous 
pleuritis subjects (B) for PPD, culture filtrate (CF) and sonicate antigens (Son Ag) of M. tuberculosis H37Rv as 
assessed by ELISA. The coating concentration of the antigens was 5µg/ml and the optical density (O.D.) was 
measured at 450nm.                
 * Represents p<0.05 in comparison with the corresponding plasma 
 # Represents p<0.05 for comparison between TP and NTP groups 
 
A pre-stained molecular weight marker (GIBCO BRL) 
was run on the same gel. 
 
Statistical analysis: The significance of the observed 
differences was calculated using paired or unpaired 
student’s t-test as appropriate.  
 
RESULTS 
 
 To understand the in vivo humoral response, the 
percentage composition of B-cells in PBMC and PFMC 
was determined. There was no significant difference in 
the levels of CD19+B-cells between PBMC and PFMC 
of TP patients. The CD19+B-cells were significantly 
lower in the PFMCs of non-tuberculous pleuritis 
patients when compared to their PBMCs (Fig. 1). 
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Fig.1: Percentage of B-cells in PBMC and PFMC in 
44 TP and 30 NTP patients: The percentage of 
B-cells was determined using a double staining 
protocol by FACS. The mean levels (± 
S.E.M.) are represented in the graph. 
*Represents p<0.05 
 
 
Fig. 2: Western blot analysis of culture filtrate antigen 
of H37Rv: The band patterns recognised by 
plasma and pleural fluid of 20 tuberculous 
pleuritis subjects (A-lanes 1 to 20) and 10 non-
tuberculous pleuritis control subjects (B-lanes 
1 to 10). Molecular weight markers in 
kilodaltons (kDa) are indicated on the left (M). 
B-blank, P-pooled TB plasma, N-pooled 
normal plasma, T-pooled tuberculous pleuritis 
plasma. 
 
 The systemic levels of CD19+B-cells in NTP were 
higher than in TP patients. The levels of antibodies did 
not differ significantly between plasma and pleural 
fluid of TP patients except for IgG levels against CF 
antigens and IgM levels against PPD, where the 
antibody levels were significantly lower in pleural fluid 
when compared with plasma (Table 1a). Interestingly in 
non-tuberculous pleuritis patients, the antibody levels in 
the pleural fluid against all the mycobacterial antigens 
were significantly lower than the plasma antibody 
levels (Table 1b). The IgG levels were  higher in  PF of  
*
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Fig. 3: Graphical analysis of the antibody reactivity 
patterns as observed in figure 2: The frequency 
of reaction of the plasma of tuberculous 
pleuritis subjects (TP) with a given antigen 
band is plotted against frequency with non-
tuberculous pleuritis subjects (NTP). The 
apparent molecular weight is indicated 
alongside. The dots lying on x-axis represents 
the molecular weights of 25, 33, 124, 110, 70, 
31 and 132kDa respectively. These antigens 
were recognised only by TP subjects 
 
TP than NTP subjects for PPD and CF antigens. The 
IgA and IgM antibody levels did not differ in the 
plasma of the two groups for all the antigens (Table 1a 
and b).   
 There was a differential recognition of the culture 
filtrate antigens of mycobacteria between TP and Non-
TP patients by western blot. However there was no 
difference in the antigen recognition patterns of plasma 
and pleural fluid of the same patients in both the groups 
(Fig. 2a and b). Some of the antigens were recognised 
in both TP and NTP subjects and some were 
exclusively  recognized by TP plasma and pleural fluid. 
The antigens of molecular weight 25, 31, 33, 70, 110, 
124 and 132 kDa were  recognized exclusively by the 
TP patients. The frequency of recognition of some of 
the culture filtrate antigens on an immunoblot is shown 
in Fig. 3.  
 
DISCUSSION 
 
 Pleural tuberculosis is a self-limiting illness. The 
fact that the recurrent pleurisy is rare indicates that 
there occurs the adequate local and protective immune 
response. The successful self-elimination of the 
condition is brought out by the compartmentalized 
CD4+Th1 immune response in TP[2,17].  Although the 
inevitable role of the CD4+T cells and the Th1 
cytokines in limiting the illness is well documented, 
much less is known about the contribution of B-cell 
mediated immunity in tuberculous pleuritis [18, 19].  
 The absence of any significant difference in the 
number of B-cells between the pleural fluid and blood 
in TP, observed in the present study indicates the 
absence of compartmentalization of these cells. A 
similar observation was reported by Santiago et al.,[20].  
These results show that there is no quantitative 
difference in the B-cell mediated response. However, 
the report by Wallis et al showed that the tuberculous 
pleural fluid contains a high proportion of antigen 
reactive B-cells[21]. Also they had generated the clones 
of B-cells from pleural fluid that were reactive to 
specific antigens in the range from 29kDa to 68kDa. 
This indicates that there occurs mycobacterial antigen 
specific B-cell clonal propagation at the site of infection 
and it is important to analyze them for further 
development in vaccine and/or diagnosis.    
 In our study, though the IgG levels for PPD were 
significantly higher in PF of TP than NTP subjects, the 
levels of other isotype of antibodies did not differ. 
Banchuin et al have reported the absence of significant 
difference in the IgG levels for PPD in pleural fluid 
between patients with tuberculosis and malignancy[22]. 
A contrary report by Murate et al, demonstrated a 
significant increase of all the three isotypes (IgA, IgG 
and IgM) for PPD in the tuberculous pleural effusion 
than the malignant pleurisy[23].   
 There are very few reports on the pleural antibody 
response to secretary antigens of mycobacteria. Most of 
these studies have documented the usefulness of a 
single or the combination of purified secretary antigens 
of mycobacteria in serological or pleural fluid 
diagnosis[24-26]. And there are no reports that compare 
the systemic verses local antibody response to the 
secretary antigens and its usefulness in discriminating 
the non-tuberculous pleuritis subjects. Our results 
indicate that the local antibody production, against the 
culture filtrate antigens does not differ significantly 
from that of the systemic levels. Nevertheless the 
differential antigen recognition on western blot by TP 
and NTP subjects supports the suggestion of Wallis et 
al., [21], that tuberculous pleurisy may prove useful in 
the identification of potentially protective 
mycobacterial antigens particularly those secreted 
during infection. Of particular interest from our study is 
the low Mol.wt. proteins of 31and 33kDa which were 
recognized only by the TP subjects as also reported by 
Wallis et al., [21]. The larger proportion of patients 
recognized the antigens in the high molecular weight 
region of 70-130kDa, particularly 70, 110, 124  and 
132kDa proteins. It suggests that these secreted 
antigens of M. tuberculosis, elicit antibodies in majority 
of TP patients. A similar observation was reported by 
Laal et al in patients with pulmonary tuberculosis[27]. 
This shows that the antigens of high molecular weight 
have an important role in the protective immune 
response. Characterization of such proteins is essential 
to understand their role in pathogenesis of tuberculosis. 
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 In the present study, the individual antibody 
response of isotypes IgA and IgM to the mycobacterial 
antigens did not show any appreciable difference 
between the TP and NTP subjects. Also NTP subjects 
recognized some of the secretary antigens of 
mycobacteria. This might be due to the high prevalence 
of tuberculosis in our country and all of the non-TP 
subjects recruited in the study are infected with 
mycobacteria as evident from their mantoux status. This 
is supported by the fact that the anti-mycobacterial 
antibody detection has modest diagnostic value for 
tuberculosis and tuberculous pleuritis in area with 
intermediate or high prevalence of tuberculosis[26].  
 Together our data suggests that the antibodies 
present in the pleural fluid might probably be due to the 
passive diffusion from the plasma rather than the local 
production as reported previously[28]. However studies 
that employed single or multiple, purified or 
recombinant antigens support the concept of the local 
antibody production in TP pleuritis[21, 26]. Such studies 
employing purified antigens have to be carried out 
particularly in an endemic area to ascertain whether 
there is local antibody production against specific 
antigens of mycobacteria. Thus our study demonstrates 
that the local humoral anti-mycobacterial response does 
not differ extensively from the systemic humoral 
immune response in tuberculous pleuritis.  
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